Clinical Lipidology and Cardiovascular Risk Practice Test

131 preguntas disponibles

Gana confianza para Clinical Lipidology and Cardiovascular Risk. Practica los conceptos, comprende las respuestas y refuerza tus conocimientos pregunta a pregunta.

Probar una pregunta

Prueba 5 preguntas gratis

No necesitas cuenta. Una cuenta gratuita incluye 20 preguntas de este examen.

131 Preguntas de práctica

2 horas 11 minutos Tiempo de Práctica

Prueba 5 preguntas gratis

No necesitas cuenta. Una cuenta gratuita incluye 20 preguntas de este examen.

El banco 131 Preguntas de práctica verificadas con los objetivos oficiales.

131 preguntas de práctica

Descripción y detalles del examen

Questions cover lipoprotein metabolism, lipid disorders, cardiovascular risk assessment, and pharmacologic and non-pharmacologic management concepts. This practice supports people building or checking clinical lipidology knowledge and reasoning through patient-centered scenarios. Administered by ABIM/NLA. Key domains include Atherosclerosis Pathogenesis and Risk Assessment, Genetic Dyslipidemias and Classification, Lipid Measurement and Laboratory Interpretation and Lipoprotein Metabolism and Physiology.

Preguntas de Muestra

Elige una respuesta y consulta la explicación para ver cómo funciona la práctica.

Genetic and Secondary Dyslipidemias

A patient sent for 'genetic cholesterol disease' has new isotretinoin therapy and triglycerides 720 mg/dL. What is the most appropriate next diagnostic move?

Pharmacologic Therapy, Outcomes Trials, Safety, and Monitoring

A patient asks how colesevelam works and why it was chosen. Which explanation is best?

Special Populations and Complex Lipid Consults

A pediatric referral involves a 16-year-old with obesity, triglycerides 510 mg/dL, A1c 6.7%. Which response best reflects lipid-specialist practice?

Lifestyle, Nutrition, Obesity, and Behavioral Counseling

A clinician is counseling a patient with triglycerides 340 mg/dL, A1c 8.7%, sweetened beverages daily. Which nutrition recommendation is most evidence-based?

ASCVD Risk Assessment, Biomarkers, Imaging, and Evidence Interpretation

A clinician asks which biomarker matters in a patient with non-HDL-C 186 mg/dL with triglycerides 430 mg/dL. Which interpretation is most accurate?